Our findings provide the first evidence that a decrease in COMP is a novel biomarker of TAD and that COMP could be a potential therapeutic target to prevent TAD progression.PerspectivesCOMPETENCY IN MEDICAL KNOWLEDGE: TAD is a life-threatening cardiovascular disease associated with high morbidity and mortality. Here, COMP is linked to cardiovascular disorder.